ORIC Pharmaceuticals Inc [ORIC] stock is trading at $8.43, up 1.93%. An important factor to consider is whether the stock is rising or falling in short-term value. The ORIC shares have gain 2.55% over the last week, with a monthly amount drifted -28.50%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
ORIC Pharmaceuticals Inc [NASDAQ: ORIC] stock has seen the most recent analyst activity on November 20, 2025, when Evercore ISI initiated its Outperform rating and assigned the stock a price target of $25. Ladenburg Thalmann started tracking the stock assigning a Buy rating and suggested a price target of $15 on July 08, 2025. Wells Fargo initiated its recommendation with an Overweight and recommended $20 as its price target on October 31, 2024. Stifel started tracking with a Buy rating for this stock on September 06, 2024, and assigned it a price target of $20. In a note dated February 23, 2024, Cantor Fitzgerald initiated an Overweight rating.
ORIC Pharmaceuticals Inc [ORIC] stock has fluctuated between $3.90 and $14.93 over the past year. Currently, Wall Street analysts expect the stock to reach $22 within the next 12 months. ORIC Pharmaceuticals Inc [NASDAQ: ORIC] shares were valued at $8.43 at the most recent close of the market. An investor can expect a potential return of 160.97% based on the average ORIC price forecast.
Analyzing the ORIC fundamentals
Gross Profit Margin for this corporation currently stands at -0.07% with Operating Profit Margin at -138.86%, Pretax Profit Margin comes in at -126.89%, and Net Profit Margin reading is -126.89%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is -0.45 and Total Capital is -0.36.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.27 points at the first support level, and at 8.12 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.60, and for the 2nd resistance point, it is at 8.78.
Ratios To Look Out For
For context, ORIC Pharmaceuticals Inc’s Current Ratio is 14.65. On the other hand, the Quick Ratio is 14.65, and the Cash Ratio is 2.46.
Transactions by insiders
Recent insider trading involved Multani Pratik S, Chief Medical Officer, that happened on Dec 16 ’25 when 10720.0 shares were sold. Chief Financial Officer, Piscitelli Dominic completed a deal on Dec 16 ’25 to sell 10720.0 shares. Meanwhile, PRESIDENT AND CEO Chacko Jacob sold 33374.0 shares on Dec 16 ’25.
